Navigation Links
UCI study points to new means of overcoming antiviral resistance in influenza
Date:7/12/2011

Irvine, Calif., July 12, 2011 UC Irvine researchers have found a new approach to the creation of customized therapies for virulent flu strains that resist current antiviral drugs.

Using powerful computer simulations, UCI's Rommie Amaro and Robin Bush created a method to predict how pocket structures on the surface of influenza proteins promoting viral replication can be identified as these proteins evolve, allowing for possible pharmaceutical exploitation.

"Our results can influence the development of new drugs taking advantage of this unique feature," said Amaro, assistant professor of pharmaceutical sciences and computer science. The study appears online in Nature Communications.

The search for effective flu drugs has always been hampered by the influenza virus itself, which mutates from strain to strain, making it difficult to target with a specific pharmaceutical approach.

The most common clinical flu treatments are broad-based and only partially effective. They work by interrupting the action of an enzyme protein in the virus called neuraminidase, which plays a critical role in viral replication.

In 2006, scientists discovered that avian influenza neuraminidase exhibited a distinctive, pocket-shaped feature in the area pinpointed by clinically used drugs. They named it the 150-cavity.

Amaro and Bush, associate professor of ecology & evolutionary biology, conducted research at the San Diego Supercomputer Center and the National Institute for Computational Sciences to learn the conditions under which the pockets form.

They created molecular simulations of flu proteins to predict how these dynamic structures move and change and where and when the 150-cavity pockets will appear on the protein surface. This sequence analysis method could be utilized on evolving flu strains, providing vital information for drug design, Amaro said.

She added: "Having additional antivirals in our treatment arsenal would be advantageous and potentially critical if a highly virulent strain for example, H5N1 evolved to undergo rapid transmission among humans or if the already highly transmissible H1N1 pandemic virus was to develop resistance to existing antiviral drugs."


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related biology news :

1. Owl study expands understanding of human stereovision
2. Virginia Tech Coal and Energy Center selected for study of CO2 injection into storage reservoirs
3. Large human study links phthalates, BPA and thyroid hormone levels
4. University of Houston researcher an author of multi-institutional genetic study of ovarian cancer
5. Study offers new clues about hereditary spastic paraplegia
6. Study suggests new strategy to prevent infertility, birth defects
7. UTMB-led researchers awarded $7.8 million for Gulf spill study
8. LSUHSC conducts landmark study of mid, long-term health effects of oil exposure
9. Nordic study shows marginally higher but overall low risk of stillbirth in ART children
10. First whole-genome lung cancer study by TGen and Virginia G. Piper Cancer Center set for conference
11. Twin study shows lifestyle, diet can significantly influence course of macular degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... , March 21, 2017 Vigilant Solutions ... serving law enforcement agencies, announced today the appointment of ... director of public safety business development. Mr. ... enforcement experience, including a focus on the aviation transportation ... most recent position, Mr. Sheridan served as the Aviation ...
Breaking Biology News(10 mins):
(Date:7/17/2017)... ... July 17, 2017 , ... ... software company AB Cube has joined its eHealth App xChange ™, ... innovation across life sciences and healthcare. Under the partnership, AB Cube’s comprehensive, ...
(Date:7/17/2017)... ... July 17, 2017 , ... Co-Diagnostics, ... developed and intends both to manufacture and sell reagents used for diagnostic tests, ... Market. , Headquartered in Sandy, Utah, Co-Diagnostics’ intellectual property and technologies are protected ...
(Date:7/15/2017)... ... ... Cuvette manufacturer FireflySci has been making many products for the ... have learned that their biggest asset was their amazing customer base. Through listening ... to meet the changing needs of scientists at a rapid pace. , For decades, ...
(Date:7/14/2017)... ... July 14, 2017 , ... Diagenode and PreOmics ... to clean peptides for mass spectrometry (MS) analysis combining the PreOmics in-StageTip Kit ... Kit is based on proprietary technology that contains optimized buffer systems permitting ultrafast ...
Breaking Biology Technology: